(Q30748992)

English

Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

Europe PubMed Central

Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

phase I clinical trial

0 references

object named as

Andrew Vickers

1

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

7-8

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1069-1079

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Discovery and development of antineoplastic agents from natural sources

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

ABC of complementary medicine: herbal medicine

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Inhibition of sensitization reactions induced by certain aldehydes

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Indinavir concentrations and St John's wort.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9).

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Immunomodulation by orally administered beta-glucan in mice

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Activity of maitake D-fraction to inhibit carcinogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: A randomised controlled study

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rate

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Tea and cancer prevention: an evaluation of the epidemiologic literature

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Green tea consumption and the risk of pancreatic and colorectal cancers.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Effects of green tea catechins in a rat multi-organ carcinogenesis model

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Mistletoe treatment for cancer review of controlled trials in humans

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Phase I clinical trial design in cancer drug development

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120005926

21 January 2018

Identifiers

10.1081/CNV-120005926

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30748992&oldid=1749475179"